Needham & Company Downgrades Cardiovascular Systems (CSII) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Cardiovascular Systems Reports Preliminary Fiscal First-Quarter Financial Results
October 7, 2015 4:00 PM EDTConference Call Scheduled for Today, Oct. 7, 2015, at 3:45 PM CT (4:45 PM ET)
Revenue is approximately $43.9 million, up 11 percent over prior-years first quarter, excluding Asahi guide wire sales in the prior period, but below guidance range Net loss is expected to be from $(0.41) to $(0.43) per common shareST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today reported preliminary results for its fiscal 2016 first quarter ended September 30, 2015.
The company expects fiscal first-quarter revenues of approximately... More



